Jenna Tocci

Jenna is joining Atalanta from Voyager Therapeutics, where she was a part of the in vivo neuroscience group, targeting neurodegenerative diseases using AAV mediated gene therapy. Prior to her time at Voyager, Jenna was at Abpro in the pre-clinical department working in vivo on antibody immunotherapies to target various cancers. Jenna graduated from Mound Ida College with a BS in Veterinary Technology/Veterinary Sciences.